Illumina | ILMN - Loan Capital


Illumina reported $1.49B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Agilent USD 3.64B 594M Jun/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Bruker USD 1.81B 151.8M Jun/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Danaher USD 25.15B 7.59B Jun/2026
Dentsply International USD 2B 10M Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Illumina USD 1.49B 1000K Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.7B 284M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Mettler Toledo International USD 2.04B 116.92M Jun/2026
Myriad Genetics USD 120.7M 400K Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quest Diagnostics USD 5.63B 477M Jun/2026
Quidel USD 2.54B 2.54B Jun/2026
Repligen USD 551.05M 4.46M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Standard Biotools USD 299K 0 Mar/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Waters USD 5.09B 129M Jun/2026